Related stories
FDA Approves Sanofi’s Infilbray for Gaucher Disease Type 3 Symptoms
The FDA approved Sanofi’s Infilbray for neurological symptoms of Gaucher disease type 3.
M impact | REGULATION | Nov 18, 2026, 10:19 PM UTC
InnovAge Settles DOJ and State Civil Matter for About $37 Million
InnovAge said it executed a settlement agreement with the U.S. Department of Justice and participating states for about $37 million.
M impact | REGULATION | Nov 18, 2026, 09:07 PM UTC
US FDA approves Sanofi genetic disorder drug
The US FDA approved a Sanofi drug for a genetic disorder.
M impact | REGULATION | Nov 18, 2026, 08:44 PM UTC
US Judge Rejects JPMorgan Bid to Dismiss Sexual Harassment Case
A US judge rejected JPMorgan Chase’s bid to dismiss a sexual harassment case.
M impact | REGULATION | Nov 18, 2026, 08:25 PM UTC
US Sanctions Hezbollah-Linked Charity, Treasury Says
The US Treasury says it sanctioned a charity linked to Hezbollah as part of a push against Iran’s proxies.
M impact | REGULATION | Nov 18, 2026, 06:38 PM UTC
EU Governments Authorise Signature of Trade Deal With Indonesia
EU governments authorised signature of a trade agreement with Indonesia.
L impact | REGULATION | Nov 18, 2026, 06:24 PM UTC